The heterogeneity of "major depression".
作者信息
Goldberg David
机构信息
Institute of Psychiatry, King's College, London, UK.
出版信息
World Psychiatry. 2011 Oct;10(3):226-8. doi: 10.1002/j.2051-5545.2011.tb00061.x.
Abstract
摘要
相似文献
1
The heterogeneity of "major depression".“重度抑郁症”的异质性
World Psychiatry. 2011 Oct;10(3):226-8. doi: 10.1002/j.2051-5545.2011.tb00061.x.
2
Causes and Consequences of Diagnostic Heterogeneity in Depression: Paths to Discovering Novel Biological Depression Subtypes.抑郁症诊断异质性的原因及后果：发现新型生物性抑郁症亚型的途径
Biol Psychiatry. 2020 Jul 1;88(1):83-94. doi: 10.1016/j.biopsych.2020.01.012. Epub 2020 Jan 28.
3
Simultaneous Decomposition of Depression Heterogeneity on the Person-, Symptom- and Time-Level: The Use of Three-Mode Principal Component Analysis.在个体、症状和时间层面同时分解抑郁异质性：三模态主成分分析的应用
PLoS One. 2015 Jul 15;10(7):e0132765. doi: 10.1371/journal.pone.0132765. eCollection 2015.
4
Decomposing the heterogeneity of depression at the person-, symptom-, and time-level: latent variable models versus multimode principal component analysis.分解个体、症状和时间层面抑郁症的异质性：潜在变量模型与多模式主成分分析
BMC Med Res Methodol. 2015 Oct 15;15:88. doi: 10.1186/s12874-015-0080-4.
5
Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.心理治疗与联合治疗在抑郁症治疗中的相对疗效：一项荟萃分析。
Eur Psychiatry. 2007 Jan;22(1):1-8. doi: 10.1016/j.eurpsy.2006.10.008. Epub 2006 Dec 27.
6
The risk of developing major depression among individuals with subthreshold depression: a systematic review and meta-analysis of longitudinal cohort studies.亚临床抑郁人群发展为重度抑郁症的风险：纵向队列研究的系统评价和荟萃分析。
Psychol Med. 2019 Jan;49(1):92-102. doi: 10.1017/S0033291718000557. Epub 2018 Mar 13.
7
Prevalence of depression in myocardial infarction: A PRISMA-compliant meta-analysis.心肌梗死中抑郁症的患病率：一项符合PRISMA标准的荟萃分析。
Medicine (Baltimore). 2019 Feb;98(8):e14596. doi: 10.1097/MD.0000000000014596.
8
Predisposition locus for major depression at chromosome 12q22-12q23.2.位于12号染色体q22 - 12q23.2区域的重度抑郁症易感基因座。
Am J Hum Genet. 2003 Dec;73(6):1271-81. doi: 10.1086/379978. Epub 2003 Nov 5.
9
Sample heterogeneity in unipolar depression as assessed by functional connectivity analyses is dominated by general disease effects.功能连接分析评估的单相抑郁症样本异质性主要由一般疾病效应主导。
J Affect Disord. 2017 Nov;222:79-87. doi: 10.1016/j.jad.2017.06.055. Epub 2017 Jun 27.
10
Treatment outcome variation between depression symptom combinations in the STAR*D study.STAR*D研究中抑郁症状组合之间的治疗结果差异。
J Affect Disord. 2016 Sep 1;201:1-7. doi: 10.1016/j.jad.2016.04.050. Epub 2016 Apr 26.
引用本文的文献
1
Why are we still using the PHQ-9? A Historical Review and Psychometric Evaluation of Measurement Invariance.我们为何仍在使用患者健康问卷-9？测量不变性的历史回顾与心理测量学评估。
Psychiatr Q. 2025 Sep 3. doi: 10.1007/s11126-025-10208-9.
2
A Phenomenological Reappraisal of Dynamical Systems in Psychopathology.精神病理学中动力系统的现象学重新评估
Psychopathology. 2025 Aug 18:1-21. doi: 10.1159/000548025.
3
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorder.一种异源三聚体G蛋白（Gsα）生物标志物可能预测重度抑郁症患者的抗抑郁反应。
Front Psychiatry. 2025 Jul 18;16:1619243. doi: 10.3389/fpsyt.2025.1619243. eCollection 2025.
4
The dietary ligands, omega-3 fatty acid endocannabinoids and short-chain fatty acids prevent cytokine-induced reduction of human hippocampal neurogenesis and alter the expression of genes involved in neuroinflammation and neuroplasticity.膳食配体、ω-3脂肪酸内源性大麻素和短链脂肪酸可防止细胞因子诱导的人类海马神经发生减少，并改变参与神经炎症和神经可塑性的基因表达。
Mol Psychiatry. 2025 Jul 16. doi: 10.1038/s41380-025-03119-5.
5
Biomarkers associated with treatment outcome in young people with depression: A systematic review.抑郁症青少年治疗结果相关生物标志物：一项系统综述。
Neurosci Appl. 2024 Jul 2;3:104082. doi: 10.1016/j.nsa.2024.104082. eCollection 2024.
6
Heart rate variability during inpatient treatment of depression.抑郁症住院治疗期间的心率变异性
J Mood Anxiety Disord. 2024 Feb 28;6:100059. doi: 10.1016/j.xjmad.2024.100059. eCollection 2024 Jun.
7
Evaluating the necessity of booster sessions in relapse prevention for depression: a longitudinal study.评估抑郁症复发预防中强化治疗阶段的必要性：一项纵向研究。
Front Psychol. 2025 Jun 24;16:1568141. doi: 10.3389/fpsyg.2025.1568141. eCollection 2025.
8
Altered static and dynamic functional connectivity in major depressive disorder accompanied by high anxiety: evidence from the REST-meta-MDD consortium.伴有高度焦虑的重度抑郁症中静态和动态功能连接的改变：来自REST-meta-MDD联盟的证据。
Front Psychiatry. 2025 Jun 9;16:1539702. doi: 10.3389/fpsyt.2025.1539702. eCollection 2025.
9
Chronic, combinatorial targeting of NMDARs and 5-HTRs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagia.对N-甲基-D-天冬氨酸受体（NMDARs）和5-羟色胺受体（5-HTRs）进行慢性联合靶向作用，可对压力诱导的持续性行为和进食减少产生持久的行为学效应。
Neuropsychopharmacology. 2025 Apr 22. doi: 10.1038/s41386-025-02107-1.
10
The social-ecological model of depressive symptoms in middle aged in China: a network analysis.中国中年人群抑郁症状的社会生态模型：一项网络分析
BMC Public Health. 2025 Apr 17;25(1):1451. doi: 10.1186/s12889-025-22699-z.
本文引用的文献
1
Enhanced care by generalists for functional somatic symptoms and disorders in primary care.基层医疗中全科医生对功能性躯体症状及障碍的强化护理。
Cochrane Database Syst Rev. 2013 Oct 18;2013(10):CD008142. doi: 10.1002/14651858.CD008142.pub2.
2
The detection and treatment of depression in the physically ill.躯体疾病患者的抑郁障碍的检测与治疗。
World Psychiatry. 2010 Feb;9(1):16-20. doi: 10.1002/j.2051-5545.2010.tb00256.x.
3
Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria.解构重度抑郁症：DSM-IV 症状标准的验证研究。
Psychol Med. 2010 Oct;40(10):1679-90. doi: 10.1017/S0033291709992157. Epub 2010 Jan 11.
4
Classification of anxiety and depressive disorders: problems and solutions.焦虑和抑郁障碍的分类：问题与解决方案。
Depress Anxiety. 2008;25(4):274-81. doi: 10.1002/da.20489.
5
Diagnosing major depressive disorder X: can the utility of the DSM-IV symptom criteria be improved?诊断重度抑郁症X：《精神疾病诊断与统计手册》第四版的症状标准效用能否得到改善？
J Nerv Ment Dis. 2006 Dec;194(12):893-7. doi: 10.1097/01.nmd.0000248970.50265.34.
6
Diagnosing major depressive disorder VIII: are some symptoms better than others?诊断重度抑郁症VIII：某些症状是否比其他症状更具诊断价值？
J Nerv Ment Dis. 2006 Oct;194(10):785-90. doi: 10.1097/01.nmd.0000240222.75201.aa.
7
Changes in depression awareness and attitudes in Australia: the impact of beyondblue: the national depression initiative.澳大利亚抑郁症认知与态度的变化：“走出忧郁”全国抑郁症倡议的影响
Aust N Z J Psychiatry. 2006 Jan;40(1):42-6. doi: 10.1080/j.1440-1614.2006.01739.x.
8
Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.基层医疗中计算机化认知行为疗法治疗焦虑和抑郁的临床疗效：随机对照试验。
Br J Psychiatry. 2004 Jul;185:46-54. doi: 10.1192/bjp.185.1.46.
9
Heritability of individual depressive symptoms.
J Affect Disord. 2004 Jun;80(2-3):125-33. doi: 10.1016/S0165-0327(03)00108-3.
10
Delivering interventions for depression by using the internet: randomised controlled trial.通过互联网提供抑郁症干预措施：随机对照试验。
BMJ. 2004 Jan 31;328(7434):265. doi: 10.1136/bmj.37945.566632.EE. Epub 2004 Jan 23.
Zotero 插件